Modern methods of phase 1 clinical trial design
Modern methods of phase 1 clinical trial design
Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from the phase III SOLAR-1 trial
Polygenic risk scores for breast cancer: ready or not?
Single cell genomics in breast cancer: breast tumour evolution and intra-tumour heterogeneity
SABCS 2018: Highlights in breast cancer treatment
Prognostic value of circulating tumour-cell count in metastatic breast cancer patients
Low-dose tamoxifen as effective as higher doses for breast cancer patients
Multiple myeloma highlights and more from ASH 2018
Results of the Beat AML umbrella study for previously untreated acute myeloid leukaemia
Myeloma XI study: Quadruplet regimen for transplant eligible patients
Developments in CAR T treatments for adult patients
ASH 2018: Expert overview of the latest in CLL, ALL and AML